Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
As treatment progresses and depending on individual response, we may adjust the dosage to optimize results
Severe abdominal pain that does not go away Signs of pancreatitis such as persistent nausea with intense stomach pain Allergic reactions including swelling of the face, lips, or throat Rapid heart rate or difficulty breathing If any side effects persist or worsen, contact your healthcare provider right away
Its clinical development for obesity was discontinued in 2007 after the pivotal 536-participant Phase IIb trial failed to meet its primary efficacy endpoint, and no formulation of the compound has received FDA approval since
This origin story is critical
This innovative GLP-1 receptor agonist has shown promising effects on metabolic health, making it a key player in managing liver-related conditions such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
US$ 28.59
US$ 22.52
US$ 20.37
US$ 21.29
US$ 22.49
